35310-76-0 Usage
Uses
Used in Pharmaceutical Industry:
Ethanone, 1-(3-bromo-4-ethoxyphenyl)is employed as a key intermediate in the synthesis of various pharmaceutical products. Its unique structure and properties make it a valuable component in the development of new drugs and medications, contributing to the advancement of healthcare and medical treatments.
Used in Agrochemical Industry:
In the agrochemical sector, Ethanone, 1-(3-bromo-4-ethoxyphenyl)serves as an essential intermediate in the production of various agrochemicals, including pesticides and herbicides. Its incorporation into these products enhances their effectiveness in protecting crops and improving agricultural yields.
Used in Specialty Chemicals Production:
Ethanone, 1-(3-bromo-4-ethoxyphenyl)is also utilized in the manufacturing of specialty chemicals, which are tailored for specific applications in various industries. Its unique properties and reactivity make it a valuable component in the development of high-performance materials, such as polymers, dyes, and coatings.
Used as a Building Block in Organic Synthesis:
Due to its reactive functional groups, Ethanone, 1-(3-bromo-4-ethoxyphenyl)can be used as a building block in organic synthesis for the preparation of a wide range of organic compounds. Its versatility allows chemists to modify and functionalize the molecule, enabling the synthesis of complex organic structures with diverse applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 35310-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,3,1 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 35310-76:
(7*3)+(6*5)+(5*3)+(4*1)+(3*0)+(2*7)+(1*6)=90
90 % 10 = 0
So 35310-76-0 is a valid CAS Registry Number.
35310-76-0Relevant academic research and scientific papers
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
-
Paragraph 2246, (2019/03/30)
The invention discloses compounds of Formula (I), wherein A1, R1, R2, R3, R4, and n are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
